CL2023003646A1 - Métodos de purificación de columnas de vectores aav. - Google Patents

Métodos de purificación de columnas de vectores aav.

Info

Publication number
CL2023003646A1
CL2023003646A1 CL2023003646A CL2023003646A CL2023003646A1 CL 2023003646 A1 CL2023003646 A1 CL 2023003646A1 CL 2023003646 A CL2023003646 A CL 2023003646A CL 2023003646 A CL2023003646 A CL 2023003646A CL 2023003646 A1 CL2023003646 A1 CL 2023003646A1
Authority
CL
Chile
Prior art keywords
purification methods
aav vectors
column purification
full
particles
Prior art date
Application number
CL2023003646A
Other languages
English (en)
Spanish (es)
Inventor
Khanal Ohnmar
Kumar Vijesh
Jin Mi
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of CL2023003646A1 publication Critical patent/CL2023003646A1/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
CL2023003646A 2021-06-11 2023-12-05 Métodos de purificación de columnas de vectores aav. CL2023003646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US202263366094P 2022-06-09 2022-06-09

Publications (1)

Publication Number Publication Date
CL2023003646A1 true CL2023003646A1 (es) 2024-10-25

Family

ID=84426294

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2023003646A CL2023003646A1 (es) 2021-06-11 2023-12-05 Métodos de purificación de columnas de vectores aav.
CL2026000535A CL2026000535A1 (es) 2021-06-11 2026-02-24 Métodos de purificación de columnas de vectores aav.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2026000535A CL2026000535A1 (es) 2021-06-11 2026-02-24 Métodos de purificación de columnas de vectores aav.

Country Status (13)

Country Link
US (1) US20240271159A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351755A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525142A (cg-RX-API-DMAC7.html)
KR (1) KR20240021231A (cg-RX-API-DMAC7.html)
AU (1) AU2022289035A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025999A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221540A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023003646A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018191A2 (cg-RX-API-DMAC7.html)
IL (1) IL309070A (cg-RX-API-DMAC7.html)
MX (1) MX2023014809A (cg-RX-API-DMAC7.html)
PE (1) PE20240359A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022261663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528182A (ja) * 2022-08-12 2025-08-26 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 完全な組換えアデノ関連性ウイルス粒子から空の粒子を分離するための新規な陰イオン交換クロマトグラフィーの方法
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
US20260085295A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. PARTITIONING ANION EXCHANGE CHROMATOGRAPHY FOR PURIFICATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559429B2 (ja) * 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
AU2010227419A1 (en) * 2009-03-27 2011-10-20 Proyecto De Biomedicina Cima, S.L. Methods and compositions for the treatment of cirrhosis and liver fibrosis
EP3054006A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
EP3658250A4 (en) * 2017-06-30 2021-10-27 Spark Therapeutics, Inc. AAV VECTOR COLUMN CLEANING PROCEDURE
WO2023077085A2 (en) * 2021-10-29 2023-05-04 Oxford Biomedica Solutions Llc Methods and compositions for the purification of adeno-associated virus
JP2025535118A (ja) * 2022-10-11 2025-10-22 メイラグティーエックス ユーケー アイアイ リミティド Aavカプシドの精製のためのクロマトグラフィー方法

Also Published As

Publication number Publication date
US20240271159A1 (en) 2024-08-15
PE20240359A1 (es) 2024-02-27
CA3221540A1 (en) 2022-12-15
JP2024525142A (ja) 2024-07-10
BR112023025999A2 (pt) 2024-02-27
AU2022289035A1 (en) 2024-01-04
IL309070A (en) 2024-02-01
KR20240021231A (ko) 2024-02-16
EP4351755A1 (en) 2024-04-17
EP4351755A4 (en) 2025-04-23
WO2022261663A1 (en) 2022-12-15
CO2023018191A2 (es) 2024-01-25
CL2026000535A1 (es) 2026-06-12
MX2023014809A (es) 2024-01-29

Similar Documents

Publication Publication Date Title
MX2023014809A (es) Metodos de purificacion por columna de vectores aav.
WO2019241535A3 (en) Anion exchange chromatography for recombinant aav production
SA520420518B1 (ar) تبديل الانتحاء النسيجي للفَيروسات المُرتَبِط بالفَيروس الغُدِّيّ
MX2020006884A (es) Metodos de purificacion de virus adenoasociado.
EA202190512A1 (ru) Композиции и способы для производства векторов для генной терапии
EA202091712A1 (ru) МОДИФИЦИРОВАННЫЙ КАПСИДНЫЙ БЕЛОК rAAV ДЛЯ ГЕННОЙ ТЕРАПИИ
MX2021013266A (es) Nuevas capsides de aav y composiciones que las contienen.
MX2024009660A (es) Variantes de capside de aav y usos de las mismas.
CO2020012060A2 (es) Inhibidores de la arginasa
WO2022026632A3 (en) Improved aav-mediated x-linked retinoschisis therapies
WO2022098699A8 (en) Compositions and methods for the treatment of tauopathy
WO2018204803A8 (en) Compositions and methods of treating huntington's disease
WO2023004407A3 (en) Adeno-associated virus compositions and methods of use thereof
AU2018260998A2 (en) Modulatory polynucleotides
EP4234688A3 (en) Adeno-associated virus purification methods
ZA202203681B (en) Compositions and methods for the treatment of viral infections
MX2024005705A (es) Composiciones de liquidos ionicos.
WO2019222136A3 (en) Liver targeting adeno-associated viral vectors
BR112021020957A2 (pt) Capsídeos de vírus adenoassociado (aav) variante para liberação intravítrea
BR112022020753A2 (pt) Compostos de ligação a tau
PL3999119T3 (pl) Modyfikowane białka kapsydu aav do leczenia choroby zapalnej stawów
EA202091194A1 (ru) Вирусные векторы, содержащие области, кодирующие rdh12, и способы лечения дистрофий сетчатки
MY205041A (en) Variant rnai
WO2022226289A3 (en) Aavrh74 vectors for gene therapy of muscular dystrophies
MX2023012672A (es) Nuevo anticuerpo anti-vista estable.